Bolt Biotherapeutics (BOLT) Assets (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Assets of $48.0 million for Q1 2026, down 15.37% sequentially from $56.7 million in Q4 2025, and down 44.06% YoY from $85.9 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Assets (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Assets for 7 years, with the latest figure at $48.0 million in Q1 2026.
- Quarterly Assets fell 44.06% year-over-year to $48.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.0 million (down 44.06% YoY) and the FY2025 annual result came in at $56.7 million, down 43.04% from the prior year.
- Assets slipped to $48.0 million in Q1 2026 per BOLT's latest filing, from $56.7 million in the prior quarter.
- Over five years, Assets peaked at $282.8 million in Q1 2022 and troughed at $48.0 million in Q1 2026.
- A 5-year average of $150.3 million and a median of $142.9 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2026: Assets declined 12.89% in 2022, then slumped 44.06% in 2026.
- Over 5 years, Assets stood at $227.8 million in 2022, then dropped by 29.86% to $159.8 million in 2023, then tumbled by 37.65% to $99.6 million in 2024, then sank by 43.04% to $56.7 million in 2025, then declined by 15.37% to $48.0 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $48.0 million, $56.7 million, and $65.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | 40.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.34 Mn |
| Mar 31, 2026 | 48.03 Mn |
| Dec 31, 2025 | 56.75 Mn |
| Sep 30, 2025 | 65.05 Mn |
| Jun 30, 2025 | 75.50 Mn |
| Mar 31, 2025 | 85.86 Mn |
| Dec 31, 2024 | 99.63 Mn |
| Sep 30, 2024 | 109.33 Mn |
| Jun 30, 2024 | 124.18 Mn |
| Mar 31, 2024 | 142.89 Mn |
| Dec 31, 2023 | 159.78 Mn |
| Sep 30, 2023 | 175.36 Mn |
| Jun 30, 2023 | 190.70 Mn |
| Mar 31, 2023 | 206.18 Mn |
| Dec 31, 2022 | 227.81 Mn |
| Sep 30, 2022 | 245.51 Mn |
| Jun 30, 2022 | 260.24 Mn |
| Mar 31, 2022 | 282.79 Mn |
| Dec 31, 2021 | 307.72 Mn |
| Sep 30, 2021 | 333.55 Mn |